Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with Pranlukast, a novel leukotriene receptor antagonist

Journal of Asthma

Volumn 34, Issue 4, 1997, Pages 321-328

  Grossman, Jay ^a   Faiferman, Isidore ^b   Dubb, Jeffrey W ^b   Tompson, Debra J ^c   Busse, William ^d   Bronsky, Edwin ^e   Montanaro, Anthony ^f   Southern, Loren ^g   Tinkelman, David ^h  

^a UNIVERSITY OF ARIZONA   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

^c The Frythe   (United Kingdom)

^d University of Wisconsin Health   (United States)

^e Intermountain Allergy Group   (United States)

^f Allergy Clinic   (United States)

^g Princeton Allergy and Asthma Associates   (United States)

^h Atlanta Allergy and Immunology   (United States)

Author keywords

Asthma; Clinical trial; Leukotriene receptor antagonist; ONO 1078; Pranlukast; SB 205312

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; PRANLUKAST; SALBUTAMOL;

ADULT; AGED; ARTICLE; ASTHMA; ASTHMATIC STATE; BODY WEIGHT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; HEADACHE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SINUSITIS; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION;

EID: 0030798841     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909709067222     Document Type: Article

References (17)

1. Creticos PS, Peters SP, Adkison RM Jr, et al: Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med 310:1625 (1984).
2. Wang D, Clement P, Smitz J, Derde M-P: Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients. Eur Arch Otorhinolaryngol 252(Suppl 1):S40 (1995).
3. 4 in allergic rhinitis. Ann Allergy 60:537 (1988).
4. Ferreri NR, Howland WC, Stevenson DD, Spiegelberg HL: Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 137:847 (1988).
5. Kohi F, Miyagawa H, Agrawal DK, Bewtra AK, Townley RG: Generation of leukotriene B4 and C4 from granulocytes of normal controls, allergic rhinitis, and asthmatic subjects. Ann Allergy 65:228 (1990).
6. Henderson WR Jr: Role of leukotrienes in asthma. Ann Allergy 72:272 (1994).
7. 4-receptor antagonist improves pulmonary function in patients with mild, chronic asthma. Am Rev Respir Dis 140(5):1336 (1989).
8. 4 receptor antagonist, in subjects with bronchial asthma. Am J Respir Crit Care Med 150:618 (1994).
9. Barnes NC, Pujet J-C, on behalf of an International Study Group: Pranlukast, a novel leukotriene receptor antagonist: Results of the first European, placebo-controlled, multicentre clinical study in asthma. Thorax 1997 (in press).
10. Israel E, Cohn J, Dube L, et al, for the Zileuton Clinical Trial Group: Effect of treatment with Zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. A randomized controlled trial. JAMA 275:931 (1996).
11. Taniguchi Y, Tamura G, Honma M, et al: The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjects. J Allergy Clin Immunol 92:507 (1993).
12. 4) challenge in normal male subjects. Thorax 1997 (in press).
13. Wenzel SE: Asthma as an inflammatory disease. Ann Allergy 72:261 (1994).
14. Yamamoto H, Nagata M, Kuramitsu K, et al: Inhibition of analgesic-induced asthma by leukotriene receptor antagonist ONO-1078. Am J Respir Crit Care Med 150:254 (1994).
15. Fujimura M, Sakamoto S, Kamio Y, Matsuda T: Effect of a leukotriene antagonist, ONO-1078, on bronchial hyperresponsiveness in patients with asthma. Respir Med 87:133 (1993).
16. Taki P, Suzuki R, Tori K, et al: Reduction of the severity of bronchial hyperresponsiveness by the novel leukotriene antagonist 4-oxo-8-[4-(4-phenylbutoxy)benzoylarrunol-2-(tetrazol-5-yl)-4H-1-benzopyran hemihydrate. Drug Res 44:330 (1994).
17. Nakagawa N, Obata T, Kobayashi T, et al: In vivo pharmacologic profile of ONO-1078: A potent, selective and orally active peptide leukotriene (LT) antagonist. Jpn J Pharmacol 60:217 (1992).